Associations between underlying diseases with COVID-19 and its symptoms among adults: a cross-sectional study
Authors:
Open Access
- 13 June 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 11, 1210800
Abstract
Background: Specific underlying diseases were reported to be associated with severe COVID-19 outcomes, but little is known about their combined associations. The study was aimed to assess the relations of number of and specific underlying diseases to COVID-19, severe symptoms, loss of smell, and loss of taste.Methods: A total of 28,204 adult participants in the National Health Interview Survey 2021 were included. Underlying diseases (including cardiovascular diseases, cancer, endocrine diseases, respiratory diseases, neuropsychiatric diseases, liver and kidney diseases, fatigue syndrome, and sensory impairments), the history of COVID-19, and its symptoms were self-reported by structured questionnaires. Multivariable logistic regression models were used to assess the combined relation of total number of underlying diseases to COVID-19 and its symptoms, while mutually adjusted logistic models were used to examine their independent associations.Results: Among the 28,204 participants (mean ± standard deviation: 48.2 ± 18.5 years), each additional underlying disease was related to 33, 20, 37, and 39% higher odds of COVID-19 (odds ratio [OR]: 1.33, 95% confidence interval [CI]: 1.29–1.37), severe symptoms (OR: 1.20, 95% CI: 1.12–1.29), loss of smell (OR: 1.37, 95% CI: 1.29–1.46), and loss of taste (OR: 1.39, 95% CI: 1.31–1.49). In addition, independent associations of sensory impairments with COVID-19 (OR: 3.73, 95% CI: 3.44–4.05), severe symptoms (OR: 1.37, 95% CI: 1.13–1.67), loss of smell (OR: 8.17, 95% CI: 6.86–9.76), and loss of taste (OR: 6.13, 95% CI: 5.19–7.25), cardiovascular diseases with COVID-19 (OR: 1.13, 95% CI: 1.03–1.24), neuropsychiatric diseases with severe symptoms (OR: 1.41, 95% CI: 1.15–1.74), and endocrine diseases with loss of taste (OR: 1.28, 95% CI: 1.05–1.56) were observed.Conclusion: A larger number of underlying diseases were related to higher odds of COVID-19, severe symptoms, loss of smell, and loss of taste in a dose–response manner. Specific underlying diseases might be individually associated with COVID-19 and its symptoms.Keywords
This publication has 56 references indexed in Scilit:
- Telehealth Interventions to Support Self-Management of Long-Term Conditions: A Systematic Metareview of Diabetes, Heart Failure, Asthma, Chronic Obstructive Pulmonary Disease, and CancerJournal of Medical Internet Research, 2017
- Prevalence and Risk Factors of Self-Reported Smell and Taste Alterations: Results from the 2011–2012 US National Health and Nutrition Examination Survey (NHANES)Chemical Senses, 2015
- Hearing Impairment Associated With Depression in US Adults, National Health and Nutrition Examination Survey 2005-2010JAMA Otolaryngology–Head & Neck Surgery, 2014
- Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional studyThe Lancet, 2012
- Self-Management Education and Support in Chronic Disease ManagementPrimary Care: Clinics in Office Practice, 2012
- Validity of self-reported hearing loss in adults: performance of three single questionsRevista de Saúde Pública, 2011
- mice: Multivariate Imputation by Chained Equations inRJournal of Statistical Software, 2011
- Methylglyoxal modulates immune responses: relevance to diabetesJournal of Cellular and Molecular Medicine, 2010
- Angiotensin-converting enzyme 2 in lung diseasesCurrent Opinion in Pharmacology, 2006
- Validation of self-reported chronic conditions and health services in a managed care population11The full text of this article is available at http://www.elsevier.com/locate/ajpmonline.American Journal of Preventive Medicine, 2000